Bioject Medical Technologies In
(BJCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2006 | 06-2006 | 03-2006 | 12-2005 | 09-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,930 | -5,467 | -2,596 | -6,589 | -4,465 |
| Depreciation Amortization | 1,255 | 939 | 308 | 1,166 | 826 |
| Accounts receivable | 686 | 964 | 1,894 | -1,359 | -305 |
| Accounts payable and accrued liabilities | -446 | -476 | -344 | -24 | -380 |
| Other Working Capital | -1,648 | -843 | 1,413 | 857 | 462 |
| Other Operating Activity | 2,299 | 1,777 | -1,291 | 2,202 | 1,263 |
| Operating Cash Flow | $-3,784 | $-3,106 | $-616 | $-3,748 | $-2,599 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -650 | -1,220 | N/A | 2,326 | 2,106 |
| PPE Investments | 906 | 937 | -85 | -1,211 | -922 |
| Other Investing Activity | -128 | -83 | -38 | -192 | -131 |
| Investing Cash Flow | $128 | $-366 | $-122 | $923 | $1,052 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 2,434 | 2,434 | 2,456 | 961 | N/A |
| Debt Repayment | -1,925 | -1,660 | -264 | -1,050 | -870 |
| Common Stock Issued | 49 | 49 | N/A | 111 | 51 |
| Other Financing Activity | 2,848 | 2,848 | -96 | 0 | 1,071 |
| Financing Cash Flow | $3,406 | $3,671 | $2,097 | $21 | $252 |
| Beginning Cash Position | 1,045 | 1,045 | 1,045 | 3,849 | 3,849 |
| End Cash Position | 796 | 1,245 | 2,403 | 1,045 | 2,554 |
| Net Cash Flow | $-250 | $200 | $1,358 | $-2,803 | $-1,294 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,784 | -3,106 | -616 | -3,748 | -2,599 |
| Capital Expenditure | -156 | -124 | -85 | -1,211 | -922 |
| Free Cash Flow | -3,939 | -3,230 | -701 | -4,958 | -3,521 |